Abstract
Thank you to the authors for taking the time to read our editorial “Antipsychotic Induced Weight Gain and Metformin”1 in JAACAP and send in a letter to the editor with comments.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 795-796 |
| Number of pages | 2 |
| Journal | Journal of the American Academy of Child and Adolescent Psychiatry |
| Volume | 57 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2018 |
Funding
Disclosure: Dr. Walkup has received past research support from the National Institute of Mental Health for federally funded studies including free drug and placebo from Pfizer in 2007 to support the Child Adolescent Anxiety Multimodal study; free medication from Abbott in 2005 for the Treatment of the Early Age Media study; free drug and placebo from Eli Lilly and Co. in 2003 for the Treatment of Adolescents with Depression study. He has received honoraria and travel expenses for speaking engagements and meetings sponsored by the Tourette Association of America. He has received royalties from Guilford Press and Oxford University Press for multi-author books published about Tourette syndrome and from Wolters Kluwer for CME activity on childhood anxiety. He is an unpaid advisor to the Anxiety and Depression Association or America, the Tourette Association of America, and the Trichotillomania Learning Center Foundation. Dr. Cottingham, along with John Morrison, PhD, while at Cincinnati Children's Hospital Medical Center, patented the concept of using metformin for antipsychotic-related weight gain. The patent expired in February 2017, and, at this time, there is no profit to be gained for the authors for advocating the use of this agent, which is available as a generic agent. Financial support for the research of this concept was provided by Cincinnati Children’s Research Foundation, Eli Lilly and Co., and Abbot; Glucophage was supplied by Bristol Meyer Squibb. The patent was temporarily licensed to British Technology Group. She has served on the Advisory Board and Speaker’s Bureau and as a consultant for Eli Lilly and Co.
ASJC Scopus subject areas
- Developmental and Educational Psychology
- Psychiatry and Mental health